Rocket Pharmaceuticals Reports Q2 2026 Quarterly Results

What Happened
On August 10, 2026, Rocket Pharmaceuticals, Inc. (RCKT) announced certain financial information for the quarter ended June 30, 2026 and furnished a press release as Exhibit 99.1 to a Current Report on Form 8-K (Item 2.02). The 8-K was filed with the SEC on the same date and includes the company’s press release and an Inline XBRL cover page.

Key Details

• Filing date: August 10, 2026 (Form 8-K, Item 2.02).
• Period covered: Quarter ended June 30, 2026 (Q2 2026).
• Exhibit: Press release furnished as Exhibit 99.1 to the Form 8-K.
• Technical exhibit: Cover Page Interactive Data File (Inline XBRL) included as Exhibit 104.

Why It Matters
This 8-K contains Rocket’s latest official quarterly results and related disclosure; the press release will include the specific earnings, revenue, cash position and any management commentary or guidance for Q2 2026. Retail investors should review the attached press release (Exhibit 99.1) for the concrete financial figures and any impact on near-term outlook or funding needs.